代谢综合征和结果预测:朋友还是敌人?
Alessandro Menotti1, Paolo Emilio Puddu1,2
1Association for Cardiac Research, 00182 Rome, Italy.
Journal of cardiovascular development and disease
|November 26, 2025
概括
与传统的风险因素分析相比,代谢综合征 (MS) 分类并不能改善冠心病 (CHD) 或心血管疾病 (CVD) 事件的预测. 包括血清胆固醇显著提高了CHD事件的预测准确性.
科学领域:
- 心血管流行病学心血管流行病学
- 临床风险预测预测
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 代谢综合征 (MS) 是一组风险因素,但其在预测心血管疾病 (CVD) 事件中的实用性仍在争论中.
- 国际糖尿病联合会 (IDF) 为MS分类提供了具体的标准.
- 传统的风险因素评估是心血管疾病 (CVD) 风险预测的基石.
研究的目的:
- 评估代谢综合征 (MS) 分类是否改善了冠心病 (CHD) 和主要心血管疾病 (CVD) 致命事件的预测.
- 将MS标准的预测性能与传统的风险因素评估方法进行比较.
主要方法:
- 意大利风险因素和预期寿命 (RIFLE) 研究 (超过25,000名男性) 的流行病学数据分析.
- 考克斯比例危险模型被用于预测七年随访期间的CHD和CVD致命事件.
- 模型使用Akaike信息标准 (AIC) 进行了比较,使用和不使用血清胆固醇作为共同变量.
主要成果:
- 使用个体风险因子测量的模型显著优于IDF-MS分类.
- 与没有血清胆固醇的模型相比,一个包含血清胆固醇的模型提供了明显更好的CHD事件预测.
- 由因子分析衍生的得分显示了中间预测性表现.
结论:
- 除了传统的风险因素分析之外,IDF-MS分类对心血管事件没有额外的预测价值.
- 从心血管风险预测模型中排除血清胆固醇是一个错误.
- 血清胆固醇是主要心血管疾病 (CVD) 事件的冠心病 (CHD) 组成部分的关键预测因素.
关键词:
这就是AKAIKE信息标准.在 CHD 中,您可以使用 CHD.在CVD中,CVD是非常重要的.考克斯模型 考克斯模型对风险因素进行分析处理.代谢综合征代谢综合征结果预测结果预测.血清胆固醇是血清中的胆固醇.更多相关视频
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Coronary Artery Disease I: Introduction
857
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
857
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K
Kaplan-Meier Approach
541
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
541


